PT283 – Greg McKee – Psychedelics for Nociplastic Pain
News on January 11, 2022 from | Psychedelics Today
In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.
Source: https://psychedelicstoday.libsyn.com/pt283-greg-mckee-psychedelics-for-nociplastic-pain
